80739-812Level 3
KRAZATI (adagrasib)
**Product type:** Human Prescription Drug
**Active ingredient:** ADAGRASIB
**Strength:** 200 mg/1
**Dosage form:** Tablet, Coated
**Route:** Oral
**Labeler:** Mirati Therapeutics, Inc
**Marketing category:** NDA (NDA216340)
GET
/api/v1/systems/ndc_fda/nodes/80739-812Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.